Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18 Read more
Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lun Read more
Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress By Investing.com Read more
Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock By Investing.com Read more